Stock Events

Stock Events

Apellis Pharmaceuticals (1JK.F) Q3 2025 Earnings

31JulConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.65

-0.53

-0.4

-0.27

Details

Expected EPS

-0.407578666

Actual EPS

-0.28894800000000004

Surprise EPS

0.12

Surprise Percent

+29.11%

Description

Apellis Pharmaceuticals (1JK.F) has reported earnings of -0.28894800000000004 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.